The Mets’ young rotation gave them plenty to like in 2026, but it also made the next move pretty obvious: they still need help. Nolan McLean delivered a Rookie of the Year-caliber season, Christian Scott finally started to look like the pitcher people expected, and Zac Thornton emerged as a pleasant surprise.
That’s a strong base. It’s not enough on its own.
Veteran innings still matter, and while Tarik Skubal is the top prize in this offseason’s market, the Mets need to keep building the staff no matter how that chase plays out. One possible fit is a familiar division name: Braves right-hander Tyler Mahle.
Mahle checks a lot of boxes on paper. The 31-year-old showed that in the NL Wild Card Series, when he threw seven innings of one-run ball in Game 2 against the Phillies.
For the season, he posted a 3.99 ERA, which lines up with a solid No. 4 or No. 5 starter. He also comes with a sharper peak than most back-end arms, coming off a 2.18 ERA in 2025.
He’s also the kind of pitcher who should be affordable enough to draw real interest. He signed a one-year, $10 million deal with the Giants last offseason before landing in Atlanta at the trade deadline during San Francisco’s sell-off.
The problem isn’t the price tag. It’s everything that comes with it.
Mahle made 27 starts and threw 149 innings this season, his highest totals since 2021, when he started 33 games and logged 180 innings. That sounds encouraging until you zoom out and look at the rest of the recent track record.
The injury history is long and ugly. Mahle made 16 starts and tossed 86 2/3 innings in 2025.
In 2024, he barely pitched at all, appearing in just three games and throwing 12 2/3 innings. In 2023, he managed five starts and 25 2/3 innings.
Even in 2022, when he was healthier, he was limited to 23 starts and 120 2/3 innings. The main culprit throughout has been injuries.
This year, Mahle dealt with a hamstring injury and an abdominal injury. His missed time in 2025 came because of right shoulder fatigue from a stress reaction.
The major absence in 2023 and 2024 traced back to Tommy John surgery. Early in his career, he also dealt with a range of smaller bumps and bruises.
That history is exactly why this kind of move would feel familiar for the Mets. David Stearns has already leaned too heavily on injury-prone players, with Jorge Polanco and Luis Robert Jr. standing out as key examples from this year’s failed campaign. If that approach doesn’t change, it’s going to keep hurting the roster.
None of that wipes Mahle off the board. He still offers something useful: a veteran who can miss bats, handle a role, and maybe outproduce the slot he’s given. But if the Mets go after him, they’d need another rotation-level starter who can also work out of the bullpen and slide into the rotation when needed.
That’s the catch. Roster spots are finite, and at some point the better move may be to choose the more durable arm, even if the upside isn’t quite as tempting.
Much of it will come down to how the market develops. The real mistake would be signing Mahle and not having a backup plan.
In Other News...
Former Mets Arm Is Giving Fans A Trade Deadline Gut Check
The Mets long view this week stretches well beyond the standings, with one familiar arm offering a reminder of how quickly a roster decision can echo into October. Freddy Peralta, who was dealt from the Mets to the Tampa Bay Rays, spoke about the move and sounded content with the new role he has carved out in the ALDS, a tidy little gut check for anyone still wondering what might have been.
At the same time, the organizations future is still taking shape elsewhere, as prospect Cole Mathis is unveiling a new hitting stance in the Arizona Fall League. Between that development track and the broader postseason action, with the Dodgers beating the Braves and the Brewers topping the Padres, it is another snapshot of how one franchises present and future can overlap in a hurry. [Read more 🡒]
Mets Deadline Haul Already Features One Prospect Fans Will Obsess Over
The Mets did more than patch a roster at the trade deadline, they also added a crop of prospects who give the organization some real long-term intrigue. Among the names that landed in the system were Aidan Smith, Gabe Davis, Emilien Pitre, Billy Amick and Jefferson Rojas, a group that already gives the front office a few different developmental paths to watch as the minors fill out over the next few seasons.
Rojas stands out at the top of that list because the upside is easy to see, especially for a club that has been searching for young infield talent to keep moving forward. The evaluation around the group is less about immediate help than future value, but Rojas has emerged as the one to circle most closely, with a possible path to taking over at third base in 2027 if everything develops the way the Mets hope. [Read more 🡒]
Ronny Mauricio Feels Like A Mets Decision They Can't Delay
The Mets disappointing finish has already pushed the front office into an offseason of hard questions, and Ronny Mauricio is one of the more interesting ones on the board. After a year in which New York fell short of preseason expectations and wound up last in its division, President of Baseball Operations David Stearns offered some telling body language in his postseason press conference, where Mark Vientos went unmentioned and Mauricio came up only after a direct question.
Mauricios situation has lingered because the Mets have been cautious with his major league chances, a choice that could be tied to preserving his value. Even now, the club may see him less as an immediate lineup piece than as a possible bench competitor or trade chip, with an offseason move looking more likely than a future where they simply risk losing him on waivers. [Read more 🡒]